|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| IBC's Model Organisms for Drug Discovery | ||||||||||||||||
| April 05, 2002 | ||||||||||||||||
|
-, The Hynes Convention Center, Boston, MA August 8-9, 2002 IBC’s inaugural conference on Model Organisms for Drug Discovery provides not only an up-to-date look at the latest tools, but also case sutides of model organism applications from the end-users. Leading industry companies such as AstraZeneca, Bristol-Myers Squibb and Millennium will discuss target validation using single and multiple model systems. Aventis, Ingenium Pharmaceuticals, Deltagen, and Bristol-Myers Squibb will present single and multiple models to validate targets across multiple target classes, to elucidate mechanisms of drug action and to develop assays for identifying lead compounds. In addition, a number of model system platforms including C.elegans, Drosophila, mice, yeast, and zebrafish will be presented. |
||||||||||||||||
| Organized by: | IBC Life Sciences | |||||||||||||||
| Deadline for Abstracts: | - | |||||||||||||||
| Registration: | Five Easy Ways to Register! Phone (508) 616-5550 x1004 Fax (508) 616-5522 E-mail reg@ibcusa.com On-Line www.LifeSciencesInfo.com/2713 IBC USA Conferences, Inc. One Research Drive, Suite 400A Westborough, MA 01581-5195 |
|||||||||||||||
| E-mail: | jprudhomme@ibcusa.com | |||||||||||||||
| Posted by: | James Prudhomme | |||||||||||||||
| Host: | 208.252.12.3 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||